Kyndryl Quarterly Cash Flow Statements Chart
Quarterly
|
Annual
Kyndryl Quarterly Cash Flow Statements Table
Quarterly
|
Annual
Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2021-12-31 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||
net income | 56,000,000 | 69,000,000 | 215,000,000 | -43,000,000 | 11,000,000 | -45,000,000 | -12,000,000 | -142,000,000 | -141,000,000 | -737,000,000 | -106,000,000 | -281,000,000 | -250,000,000 | -740,000,000 |
adjustments to reconcile net income to cash from operating activities: | ||||||||||||||
depreciation and amortization: | ||||||||||||||
depreciation of property, equipment and capitalized software | 191,000,000 | 189,000,000 | 195,000,000 | 149,000,000 | 127,000,000 | 195,000,000 | 208,000,000 | 221,000,000 | 210,000,000 | |||||
depreciation of right-of-use assets | 73,000,000 | 107,000,000 | 66,000,000 | 84,000,000 | 70,000,000 | 68,000,000 | 78,000,000 | 82,000,000 | 91,000,000 | 143,000,000 | 94,000,000 | 106,000,000 | 85,000,000 | 90,000,000 |
amortization of transition costs and prepaid software | 308,000,000 | 304,000,000 | 327,000,000 | 337,000,000 | 310,000,000 | 310,000,000 | 315,000,000 | 306,000,000 | 325,000,000 | 290,000,000 | 325,000,000 | 291,000,000 | 293,000,000 | |
amortization of capitalized contract costs | 106,000,000 | 106,000,000 | 109,000,000 | 98,000,000 | 107,000,000 | 113,000,000 | 137,000,000 | 143,000,000 | 138,000,000 | 135,000,000 | 115,000,000 | 111,000,000 | 111,000,000 | |
amortization of acquisition-related intangible assets | 7,000,000 | 7,000,000 | 6,000,000 | 10,000,000 | 7,000,000 | 7,000,000 | 8,000,000 | 7,000,000 | 8,000,000 | |||||
stock-based compensation | 24,000,000 | 22,000,000 | 29,000,000 | 25,000,000 | 24,000,000 | 23,000,000 | 24,000,000 | 26,000,000 | 22,000,000 | 32,000,000 | 27,000,000 | 28,000,000 | 26,000,000 | 18,000,000 |
deferred taxes | -10,000,000 | -23,000,000 | 5,000,000 | 0 | 17,000,000 | -68,000,000 | 4,000,000 | 25,000,000 | 26,000,000 | 280,000,000 | -36,000,000 | -5,000,000 | 46,000,000 | -74,000,000 |
net (gain) loss on asset sales and other | -44,000,000 | -94,000,000 | -41,000,000 | 27,000,000 | 49,000,000 | -28,000,000 | -7,000,000 | 29,000,000 | 23,000,000 | -38,000,000 | 19,000,000 | 2,000,000 | 42,000,000 | |
change in operating assets and liabilities: | ||||||||||||||
right-of-use assets and liabilities | -88,000,000 | -102,000,000 | -67,000,000 | -80,000,000 | -65,000,000 | -66,000,000 | -74,000,000 | -92,000,000 | -103,000,000 | -86,000,000 | -82,000,000 | -109,000,000 | -84,000,000 | -65,000,000 |
workforce rebalancing liabilities | 3,000,000 | -3,000,000 | -9,000,000 | -20,000,000 | 7,000,000 | -10,000,000 | -10,000,000 | 5,000,000 | -23,000,000 | 42,000,000 | 0 | -7,000,000 | 6,000,000 | -22,000,000 |
receivables | 46,000,000 | 112,000,000 | -16,000,000 | 30,000,000 | 163,000,000 | 24,000,000 | 97,000,000 | -163,000,000 | 53,000,000 | 17,000,000 | 176,000,000 | 249,000,000 | 222,000,000 | |
accounts payable | -269,000,000 | 176,000,000 | -28,000,000 | -115,000,000 | -122,000,000 | 34,000,000 | 155,000,000 | -351,000,000 | -143,000,000 | 47,000,000 | 54,000,000 | 195,000,000 | -14,000,000 | 215,000,000 |
taxes | 27,000,000 | 38,000,000 | -8,000,000 | -22,000,000 | -9,000,000 | 31,000,000 | 22,000,000 | -30,000,000 | -25,000,000 | 126,000,000 | -69,000,000 | 21,000,000 | 12,000,000 | 209,000,000 |
deferred costs | -1,381,000,000 | -489,000,000 | -421,000,000 | -489,000,000 | -363,000,000 | -546,000,000 | -324,000,000 | -281,000,000 | -418,000,000 | -529,000,000 | -325,000,000 | -369,000,000 | -369,000,000 | -255,000,000 |
other assets and other liabilities | 781,000,000 | 112,000,000 | -50,000,000 | 225,000,000 | -358,000,000 | 27,000,000 | -165,000,000 | 297,000,000 | -222,000,000 | 3,000,000 | -102,000,000 | -92,000,000 | -224,000,000 | 721,000,000 |
net cash from operating activities | -124,000,000 | 581,000,000 | 260,000,000 | 149,000,000 | -48,000,000 | 145,000,000 | 436,000,000 | 46,000,000 | -173,000,000 | 12,000,000 | 278,000,000 | 387,000,000 | 104,000,000 | 606,000,000 |
| ||||||||||||||
cash flows from investing activities: | ||||||||||||||
capital expenditures | -143,000,000 | -240,000,000 | -109,000,000 | -134,000,000 | -122,000,000 | -202,000,000 | -174,000,000 | -175,000,000 | -100,000,000 | -154,000,000 | -245,000,000 | |||
free cash flows | -267,000,000 | 341,000,000 | 151,000,000 | 15,000,000 | -170,000,000 | -57,000,000 | 262,000,000 | -129,000,000 | -273,000,000 | -142,000,000 | 33,000,000 | |||
proceeds from disposition of property and equipment | 45,000,000 | 13,000,000 | 16,000,000 | 30,000,000 | 24,000,000 | 4,000,000 | 15,000,000 | 113,000,000 | 6,000,000 | 3,000,000 | 10,000,000 | 3,000,000 | 7,000,000 | 6,000,000 |
acquisitions and divestitures, net of cash acquired | 1,000,000 | 2,000,000 | 183,000,000 | 0 | -46,000,000 | |||||||||
other investing activities | 22,000,000 | 22,000,000 | -49,000,000 | 29,000,000 | -22,000,000 | -5,000,000 | 18,000,000 | -34,000,000 | -19,000,000 | 15,000,000 | 52,000,000 | -47,000,000 | -13,000,000 | -1,000,000 |
net cash from investing activities | -74,000,000 | -205,000,000 | 42,000,000 | -75,000,000 | -166,000,000 | -203,000,000 | -142,000,000 | -95,000,000 | -113,000,000 | -136,000,000 | -183,000,000 | -298,000,000 | -218,000,000 | -147,000,000 |
cash flows from financing activities: | ||||||||||||||
debt repayments | -36,000,000 | -40,000,000 | -35,000,000 | -35,000,000 | -38,000,000 | -541,000,000 | -36,000,000 | -37,000,000 | -30,000,000 | -35,000,000 | -27,000,000 | -28,000,000 | -28,000,000 | |
common stock repurchases | -62,000,000 | -63,000,000 | ||||||||||||
common stock repurchases for tax withholdings | -67,000,000 | -13,000,000 | -8,000,000 | -17,000,000 | -7,000,000 | -3,000,000 | -7,000,000 | -5,000,000 | -7,000,000 | -2,000,000 | -4,000,000 | 0 | -13,000,000 | |
other financing activities | -5,000,000 | 3,000,000 | 1,000,000 | -6,000,000 | 3,000,000 | 0 | 0 | -1,000,000 | ||||||
net cash from financing activities | -170,000,000 | -114,000,000 | -71,000,000 | -50,000,000 | -51,000,000 | -47,000,000 | -43,000,000 | -42,000,000 | -38,000,000 | -41,000,000 | -31,000,000 | -28,000,000 | -41,000,000 | 1,039,000,000 |
effect of exchange rate changes on cash, cash equivalents and restricted cash | 46,000,000 | 23,000,000 | -56,000,000 | 34,000,000 | -17,000,000 | -32,000,000 | 28,000,000 | -18,000,000 | -15,000,000 | 9,000,000 | 51,000,000 | -49,000,000 | -111,000,000 | -10,000,000 |
net change in cash, cash equivalents and restricted cash | -323,000,000 | 284,000,000 | 175,000,000 | 57,000,000 | -281,000,000 | -137,000,000 | 279,000,000 | -109,000,000 | -339,000,000 | -156,000,000 | 115,000,000 | 13,000,000 | -266,000,000 | 1,490,000,000 |
cash, cash equivalents and restricted cash at beginning of period | 1,789,000,000 | 0 | 0 | 0 | 1,554,000,000 | 0 | 0 | 0 | 1,860,000,000 | |||||
cash, cash equivalents and restricted cash at end of period | 1,466,000,000 | 284,000,000 | 175,000,000 | 57,000,000 | 1,273,000,000 | -137,000,000 | 279,000,000 | -109,000,000 | 1,521,000,000 | |||||
supplemental data | ||||||||||||||
income taxes paid, net of refunds received | 67,000,000 | 26,000,000 | 34,000,000 | 35,000,000 | 54,000,000 | 51,000,000 | 52,000,000 | 23,000,000 | 65,000,000 | 58,000,000 | 72,000,000 | 29,000,000 | 8,000,000 | |
interest paid on debt | 39,000,000 | 19,000,000 | 40,000,000 | 20,000,000 | 40,000,000 | 10,000,000 | 49,000,000 | 13,000,000 | 46,000,000 | 9,000,000 | 55,000,000 | -4,000,000 | 38,000,000 | |
proceeds from issuance of debt, net of debt issuance costs | ||||||||||||||
goodwill impairment | ||||||||||||||
net transfers (to) from parent | ||||||||||||||
depreciation and amortization | ||||||||||||||
amortization of intangible assets | 10,000,000 | 11,000,000 | 11,000,000 | 14,000,000 | ||||||||||
depreciation of property and equipment | 232,000,000 | 221,000,000 | 228,000,000 | 295,000,000 | ||||||||||
net transfers to parent | ||||||||||||||
cash, cash equivalents and restricted cash at april 1 | 0 | 0 | 2,154,000,000 | |||||||||||
cash, cash equivalents and restricted cash at december 31 | ||||||||||||||
net transfers from parent | ||||||||||||||
cash, cash equivalents and restricted cash at september 30 | ||||||||||||||
payments for property and equipment and capitalized software | -213,000,000 | |||||||||||||
cash, cash equivalents and restricted cash at june 30 | 1,888,000,000 | |||||||||||||
payments for property and equipment | -152,000,000 | |||||||||||||
cash, cash equivalents and restricted cash at january 1 | 0 | |||||||||||||
amortization of deferred costs | ||||||||||||||
amortization of intangibles | ||||||||||||||
accounts receivable | ||||||||||||||
proceeds from new debt | ||||||||||||||
payments to settle debt |
We provide you with 20 years of cash flow statements for Kyndryl stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Kyndryl stock. Explore the full financial landscape of Kyndryl stock with our expertly curated income statements.
The information provided in this report about Kyndryl stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.